Cory G Garvin

574 total citations
7 papers, 433 citations indexed

About

Cory G Garvin is a scholar working on Epidemiology, Infectious Diseases and Geriatrics and Gerontology. According to data from OpenAlex, Cory G Garvin has authored 7 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Geriatrics and Gerontology. Recurrent topics in Cory G Garvin's work include Antimicrobial Resistance in Staphylococcus (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pneumonia and Respiratory Infections (2 papers). Cory G Garvin is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers) and Pneumonia and Respiratory Infections (2 papers). Cory G Garvin collaborates with scholars based in United States. Cory G Garvin's co-authors include Richard S. Muther, Harold J. Manley, Cynthia A. Sanoski, Joseph J. Saseen, Paul P. Dobesh, John E. Murphy, Jean M. Nappi, Sarah A. Spinler, Timothy E. Welty and John A. Bosso and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Nephrology Dialysis Transplantation and Drug Safety.

In The Last Decade

Cory G Garvin

7 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cory G Garvin United States 6 214 160 92 68 66 7 433
Saurav Ghimire Australia 9 108 0.5× 82 0.5× 73 0.8× 126 1.9× 67 1.0× 13 545
Phyllis Lau Australia 12 195 0.9× 71 0.4× 200 2.2× 18 0.3× 89 1.3× 57 662
Connie Van Australia 16 184 0.9× 101 0.6× 211 2.3× 21 0.3× 122 1.8× 46 606
Marilyn Stebbins United States 14 164 0.8× 75 0.5× 123 1.3× 15 0.2× 49 0.7× 34 378
Stephanie W. Ong Canada 9 72 0.3× 37 0.2× 117 1.3× 54 0.8× 27 0.4× 14 278
Andrew Steele United States 14 47 0.2× 85 0.5× 124 1.3× 100 1.5× 23 0.3× 24 566
Léon Wilmotte Belgium 6 380 1.8× 33 0.2× 68 0.7× 38 0.6× 92 1.4× 8 536
Marianne F. Ivey United States 14 212 1.0× 55 0.3× 70 0.8× 18 0.3× 109 1.7× 58 567
Maxwell Ogochukwu Adibe Nigeria 11 115 0.5× 71 0.4× 88 1.0× 14 0.2× 46 0.7× 67 472
Oralia V. Bazaldua United States 12 230 1.1× 50 0.3× 141 1.5× 8 0.1× 53 0.8× 21 561

Countries citing papers authored by Cory G Garvin

Since Specialization
Citations

This map shows the geographic impact of Cory G Garvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cory G Garvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cory G Garvin more than expected).

Fields of papers citing papers by Cory G Garvin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cory G Garvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cory G Garvin. The network helps show where Cory G Garvin may publish in the future.

Co-authorship network of co-authors of Cory G Garvin

This figure shows the co-authorship network connecting the top 25 collaborators of Cory G Garvin. A scholar is included among the top collaborators of Cory G Garvin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cory G Garvin. Cory G Garvin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Murphy, John E., Jean M. Nappi, John A. Bosso, et al.. (2006). American College of Clinical Pharmacy's Vision of the Future: Postgraduate Pharmacy Residency Training as a Prerequisite for Direct Patient Care Practice. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(5). 722–733. 230 indexed citations
2.
Manley, Harold J., et al.. (2004). Medication prescribing patterns in ambulatory haemodialysis patients: comparisons of USRDS to a large not-for-profit dialysis provider. Nephrology Dialysis Transplantation. 19(7). 1842–1848. 143 indexed citations
3.
Bearden, David T. & Cory G Garvin. (2002). Recombinant Human Activated Protein C for Use in Severe Sepsis. Annals of Pharmacotherapy. 36. 1424–1429. 1 indexed citations
4.
McBurney, Christopher R., et al.. (2002). Trimethoprim‐Sulfamethoxazole Activity and Pharmacodynamics against Glycopeptide‐Intermediate Staphylococcus aureus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(8). 983–989. 18 indexed citations
5.
Bearden, David T. & Cory G Garvin. (2002). Recombinant Human Activated Protein C for Use in Severe Sepsis. Annals of Pharmacotherapy. 36(9). 1424–1429. 8 indexed citations
6.
Martin, Steven J., Rose Jung, & Cory G Garvin. (2001). A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections. Drug Safety. 24(3). 199–222. 22 indexed citations
7.
Martin, Steven J., et al.. (2001). The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin, against penicillin- and erythromycin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy. 47(5). 581–587. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026